Industry News Archive

Webcast for Lynparza PAOLA-1 Launch

Join professionals from across the country for an expert discussion on Lynparza (olaparib, AstraZeneca), and Lynparza + bevacizumab as maintenance monotherapy or combination therapy in advanced ovarian cancer: results from key clinical trials.

Important Notes

  • Members will be directed to a registration site which will give them the option to choose from all 6 webcasts

  • Members will be required to input their information to register for an event

  • Members can add the event to their calendar from the registration site or the registration confirmation email

  • Members will receive a reminder email 1 day and 30 minutes prior to the webcast

Details and registration.

1801 Research Boulevard Suite 400
Rockville, MD 20850
Tel: 301.984.9496 | Fax: 301.770.1949
Email Us